FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
LZI Fentanyl III Enzyme Immunoassay
K Number: K251634
·
Decision Jun 18, 2025
Classifications
1
FEI Numbers
106
Registration Numbers
106
Same Product Code
209
Applicant Total
48
Review Days
20
Basic Information
- Device Name
- LZI Fentanyl III Enzyme Immunoassay
- K Number
- K251634
- Device Class
- FDA class 2
- Clearance Type
- Special
- Regulation Number
- 862.3650
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Lin-Zhi International, Inc.
- Date Received
- May 29, 2025
- Decision Date
- June 18, 2025
- Product Code
- DJG
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- TX
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| DJG | Enzyme Immunoassay, Opiates | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (DJG), ordered by most recent decision date.
BioSieve Fentanyl FIA Test Kit; BioSieve ToxiSmart FIA Reader
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Dochek® Multi-Drug Urine Test Dipcard Rx; Dochek® Multi-Drug Urine Test Dipcard
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Rapid Fentanyl (FYL) Test Strip, Rapid Fentanyl (FYL) Test Dipcard
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Multi-drug Urine Test Cup, Multi-drug Urine Test Dip Card, Accurature Multi-drug Urine Test Cup, Accurature Multi-drug Urine Test Dip Card
FDA 510(k)
FDA Class 2
·Clinical Toxicology
LYHER® Urine Multi-Drug Test Kit(Cup), LYHER® Urine Multi-Drug Test Kit(Cassette), LYHER® Urine Multi-Drug Test Kit(Dipcard)
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Chemtrue® Drug Screen Fentanyl/Tramadol Cup Test, Chemtrue® Drug Screen Fentanyl/Tramadol Dip Card Test, Chemtrue® Multi-Panel Drug Screen Cup Test, Chemtrue® Multi-Panel Drug Screen Dip Card Test
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Other Clearances by Lin-Zhi International, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K202007 | LZI Oxycodone III Enzyme Immunoassay | Sep 17, 2020 | Substantially Equivalent |
| K201938 | LZI Fentanyl II Enzyme Immunoassay | Aug 7, 2020 | Substantially Equivalent |
| K201223 | LZI Tramadol Enzyme Immunoassay | Jun 4, 2020 | Substantially Equivalent |
| K192299 | LZI Cotinine II Enzyme Immunoassay | Nov 21, 2019 | Substantially Equivalent |
| K181159 | LZI Fentanyl Enzyme Immunoassay | Dec 3, 2018 | Substantially Equivalent |
| DEN170010 | LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay | Apr 20, 2018 | Unknown |
| K170416 | LZI Methadone Metabolite Enzyme Immunoassay, LZI Methadone Metabolite (100 and 300) Calibrators | Jun 26, 2017 | Substantially Equivalent |
| K141320 | LZI Oral Fluid Cannabinoids Enzyme Immunoassay, LZI Oral Fluid Cannabinoids Calibrators and LZI Oral Fluid Cannabinoids Controls | May 28, 2015 | Substantially Equivalent |
| K141205 | LZI ORAL FLUID 6-ACETYLMORPHINE ENZYME IMMUNOASSAY, LZI ORAL FLUID 6-ACETYLMORPHINE CALIBRATORS (5 ML), LZI ORAL FLUID 6 | Feb 13, 2015 | Substantially Equivalent |
| K141055 | LZI HYDROCODONE; ENZYME IMMUNOASSAY, CALIBRATORS; (5ML), (15ML); CONTROLS; (5ML), (15ML) | Jun 13, 2014 | Substantially Equivalent |